Change in Optomed’s holding of treasury

Optomed Plc         Stock Exchange Release    26 November 2020 at 12.00, Helsinki

Change in Optomed’s holding of treasury

A total of 35,500 of shares have been subscribed for under the Company’s stock option plans 2009A, 2015, 2017B and 2018C and Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 26 November 2020.

The total amount of treasury shares is now 740,378.
 

Optomed Plc

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and at the end of 2019 Optomed employed 108 professionals.